33.99

2.50% 0.83

Ideaya Biosciences Inc (IDYA)

Overview News Price History Option Chain Financials Discussions Forecast

Ideaya Biosciences Inc stock is traded at $33.99, with a volume of 587.10K. It is up +2.50% in the last 24 hours and up +16.40% over the past month. IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Previous Close:

$33.16

Open:

$33.22

24h Volume:

587.10K

Relative Volume:

0.49

Market Cap:

$2.98B

Revenue:

$23.38M

Net Income/Loss:

$-155.22M

P/E Ratio:

-15.52

EPS:

-2.19

Net Cash Flow:

$-134.36M

1W Performance:

+5.76%

1M Performance:

+16.40%

6M Performance:

+77.49%

1Y Performance:

+27.78%

1-Day Range:

$32.50

$34.44

1-Week Range:

$31.70

$34.66

52-Week Range:

$13.45

$34.66

Ideaya Biosciences Inc Stock (IDYA) Company Profile

Name

Ideaya Biosciences Inc

Sector

Healthcare (1129)

Industry

Biotechnology (632)

Phone

650-443-6209

Address

5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA

Employee

131

Twitter

Next Earnings Date

2024-11-05

Latest SEC Filings

IDYA's Discussions on Twitter

Compare IDYA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IDYA Ideaya Biosciences Inc	33.99	2.91B	23.38M	-155.22M	-134.36M	-2.19
VRTX Vertex Pharmaceuticals Inc	426.76	107.15B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	755.90	77.46B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	436.38	58.90B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	918.92	56.55B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	198.76	42.58B	447.02M	-1.18B	-906.14M	-6.1812

Ideaya Biosciences Inc Stock (IDYA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-18-25	Initiated	Guggenheim	Buy
Sep-04-25	Initiated	Barclays	Overweight
Sep-04-25	Initiated	Citizens JMP	Mkt Outperform
Jul-22-25	Initiated	TD Cowen	Buy
Jul-10-25	Resumed	Goldman	Neutral
Jun-26-25	Initiated	Wells Fargo	Overweight
Nov-18-24	Initiated	Stephens	Overweight
Nov-05-24	Downgrade	Leerink Partners	Outperform → Market Perform
Oct-24-24	Initiated	UBS	Buy
Oct-15-24	Initiated	Cantor Fitzgerald	Overweight
Jul-08-24	Initiated	Mizuho	Outperform
Mar-08-24	Initiated	BTIG Research	Buy
Aug-08-23	Initiated	SVB Securities	Outperform
May-24-23	Initiated	Goldman	Buy
Apr-24-23	Upgrade	Stifel	Hold → Buy
Mar-23-23	Initiated	Berenberg	Buy
Feb-28-23	Initiated	RBC Capital Mkts	Outperform
Dec-28-22	Initiated	CapitalOne	Overweight
Oct-27-22	Initiated	Citigroup	Buy
Aug-15-22	Downgrade	Stifel	Buy → Hold
Jul-18-22	Resumed	Oppenheimer	Outperform
Mar-10-22	Upgrade	Stifel	Hold → Buy
Sep-23-21	Initiated	Stifel	Hold
Jun-04-21	Resumed	Robert W. Baird	Outperform
Mar-11-21	Initiated	Guggenheim	Buy
Oct-07-20	Initiated	Wedbush	Outperform
Sep-01-20	Initiated	Northland Capital	Outperform
Jul-13-20	Upgrade	JP Morgan	Neutral → Overweight
Jun-17-20	Reiterated	H.C. Wainwright	Buy
Apr-06-20	Initiated	H.C. Wainwright	Buy
Mar-13-20	Initiated	ROTH Capital	Buy
Oct-17-19	Initiated	Oppenheimer	Outperform
Sep-10-19	Initiated	Robert W. Baird	Outperform
Jun-17-19	Initiated	Citigroup	Buy
Jun-17-19	Initiated	JP Morgan	Neutral
Jun-17-19	Initiated	Jefferies	Buy

View All

Ideaya Biosciences Inc Stock (IDYA) Latest News

Nov 21, 2025

What analysts say about IDEAYA Biosciences Inc stockEarnings Season Recap & Unlock Smart Investment Tactics That Work - earlytimes.in

Nov 21, 2025

Nov 20, 2025

How higher bond yields impact IDEAYA Biosciences Inc. (30J) stockWeekly Trade Recap & Daily Risk Controlled Trade Plans - newser.com

Nov 20, 2025

Published on: 2025-11-20 07:13:14 - newser.com

Nov 20, 2025

Why IDEAYA Biosciences Inc. (30J) stock appears on watchlists2025 Market Overview & Risk Managed Trade Strategies - newser.com

Nov 20, 2025

What valuation multiples suggest for IDEAYA Biosciences Inc. stockQuarterly Earnings Summary & Capital Efficient Trading Techniques - newser.com

Nov 20, 2025

Nov 19, 2025

Will IDEAYA Biosciences Inc. (30J) stock top growth indexesWeekly Gains Report & Detailed Earnings Play Strategies - newser.com

Nov 19, 2025

Using AI based signals to follow IDEAYA Biosciences Inc.Market Trend Report & Fast Momentum Stock Entry Tips - newser.com

Nov 19, 2025

Will IDEAYA Biosciences Inc. (30J) stock beat revenue estimates2025 Market Outlook & AI Forecast Swing Trade Picks - newser.com

Nov 19, 2025

How IDEAYA Biosciences Inc. stock reacts to Fed rate cutsEarnings Risk Summary & Real-Time Price Movement Reports - newser.com

Nov 19, 2025

Will IDEAYA Biosciences Inc. stock see PE expansionGap Up & Weekly Chart Analysis and Trade Guides - newser.com

Nov 19, 2025

Will IDEAYA Biosciences Inc. (30J) stock profit from automation waveMarket Trend Report & Reliable Intraday Trade Alerts - newser.com

Nov 19, 2025

Published on: 2025-11-19 05:21:38 - newser.com

Nov 19, 2025

Will IDEAYA Biosciences Inc. (30J) stock extend growth storyWeekly Profit Analysis & AI Powered Market Entry Strategies - newser.com

Nov 19, 2025

Published on: 2025-11-19 03:26:31 - newser.com

Nov 19, 2025

Why retail investors pile into IDEAYA Biosciences Inc. stockProfit Target & Daily Oversold Bounce Ideas - newser.com

Nov 19, 2025

Nov 18, 2025

Is IDEAYA Biosciences Inc. stock entering bullish territoryMarket Sentiment Report & AI Forecast for Swing Trade Picks - newser.com

Nov 18, 2025

Nov 17, 2025